ZA955106B - Method for the purification of 23-e isomers of 23-imino derivatives of ll-f28249 compounds - Google Patents

Method for the purification of 23-e isomers of 23-imino derivatives of ll-f28249 compounds

Info

Publication number
ZA955106B
ZA955106B ZA955106A ZA955106A ZA955106B ZA 955106 B ZA955106 B ZA 955106B ZA 955106 A ZA955106 A ZA 955106A ZA 955106 A ZA955106 A ZA 955106A ZA 955106 B ZA955106 B ZA 955106B
Authority
ZA
South Africa
Prior art keywords
purification
isomers
compounds
imino derivatives
imino
Prior art date
Application number
ZA955106A
Other languages
English (en)
Inventor
Kenneth Alfred Martin Kremer
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ZA955106B publication Critical patent/ZA955106B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA955106A 1994-06-22 1995-06-20 Method for the purification of 23-e isomers of 23-imino derivatives of ll-f28249 compounds ZA955106B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/263,967 US5478951A (en) 1994-06-22 1994-06-22 Method for the purification of 23-E isomers of 23-imino derivatives of LL-F28249 compounds

Publications (1)

Publication Number Publication Date
ZA955106B true ZA955106B (en) 1996-12-20

Family

ID=23004003

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA955106A ZA955106B (en) 1994-06-22 1995-06-20 Method for the purification of 23-e isomers of 23-imino derivatives of ll-f28249 compounds

Country Status (20)

Country Link
US (1) US5478951A (hu)
EP (1) EP0688775B1 (hu)
JP (1) JP3817756B2 (hu)
KR (1) KR100367947B1 (hu)
CN (1) CN1063445C (hu)
AT (1) ATE214071T1 (hu)
AU (1) AU681785C (hu)
BR (1) BR9502869A (hu)
CA (1) CA2152249A1 (hu)
CZ (1) CZ288894B6 (hu)
DE (1) DE69525686T2 (hu)
DK (1) DK0688775T3 (hu)
ES (1) ES2172554T3 (hu)
HU (1) HU216278B (hu)
IL (1) IL114246A (hu)
PT (1) PT688775E (hu)
SI (1) SI0688775T1 (hu)
SK (1) SK283198B6 (hu)
TW (1) TW319770B (hu)
ZA (1) ZA955106B (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7348417B2 (en) * 2003-08-07 2008-03-25 Wyeth Method of purifying moxidectin through crystallization
CN104277050B (zh) * 2013-07-04 2016-05-04 北大方正集团有限公司 一种制备莫西克汀的方法
CN103601735B (zh) * 2013-11-08 2015-12-09 大连九信生物化工科技有限公司 一种提纯莫西克汀的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916154A (en) * 1986-09-12 1990-04-10 American Cyanamid Company 23-Imino derivatives of LL-F28249 compounds
GB8721377D0 (en) * 1987-09-11 1987-10-21 Glaxo Group Ltd Chemical compounds
NZ233680A (en) * 1989-05-17 1995-02-24 Beecham Group Plc Avermectins and milbemycins and compositions thereof
US4988824A (en) * 1989-09-11 1991-01-29 Maulding Donald R Process for the preparation of 23-(C1-C6 alkyloxime)-LL-F28249 compounds

Also Published As

Publication number Publication date
SI0688775T1 (en) 2002-06-30
KR960000890A (ko) 1996-01-25
IL114246A (en) 1998-10-30
SK283198B6 (sk) 2003-03-04
DK0688775T3 (da) 2002-06-03
JP3817756B2 (ja) 2006-09-06
IL114246A0 (en) 1995-10-31
US5478951A (en) 1995-12-26
AU2176695A (en) 1996-01-04
CN1117969A (zh) 1996-03-06
CZ288894B6 (cs) 2001-09-12
AU681785B2 (en) 1997-09-04
JPH0853456A (ja) 1996-02-27
ES2172554T3 (es) 2002-10-01
HUT72831A (en) 1996-05-28
KR100367947B1 (ko) 2003-03-26
DE69525686T2 (de) 2002-09-12
HU216278B (hu) 1999-05-28
SK82495A3 (en) 1996-01-10
CA2152249A1 (en) 1995-12-23
TW319770B (hu) 1997-11-11
EP0688775A1 (en) 1995-12-27
HU9501834D0 (en) 1995-08-28
BR9502869A (pt) 1996-11-05
AU681785C (en) 2007-11-01
EP0688775B1 (en) 2002-03-06
CZ153895A3 (en) 1996-01-17
DE69525686D1 (de) 2002-04-11
CN1063445C (zh) 2001-03-21
ATE214071T1 (de) 2002-03-15
PT688775E (pt) 2002-07-31

Similar Documents

Publication Publication Date Title
HUT66563A (en) N-acetonylbenzamide derivatives and fungicidal compositions containing them
HU9601991D0 (en) Metalloproteinase inhibitors
NO992549L (no) Sukkerforbindelse, geleringsmiddel og fremgangsmåte for fremstilling derav
AU3107397A (en) Crystals of a vitamin D derivative and a method for the preparation thereof
ZA955106B (en) Method for the purification of 23-e isomers of 23-imino derivatives of ll-f28249 compounds
ZA953975B (en) Glucopyranoside benzothiophenes
HUT63734A (en) Fish-breeding method
FI951350A0 (fi) Menetelmä substituoitujen imisadsoliyhdisteiden käyttökelpoisten välituotteiden syntetisoimiseksi
PL300834A1 (en) Arylidine 1-azacycloalkanes and aryl alkyl 1-azacycloalkanes, therapeutic agents containing them and method of obtaining sames
HU913900D0 (en) Method for producing 2-halogen-pyrrhole-3-carbonitrile derivatives
SE8704542D0 (sv) New derivatives of cysteine
ZA973985B (en) Iminoxy derivatives of fenamate compounds as inhibitors of prostaglandin biosynthesis.